CClinicalTrials.gg
RecruitingNCT07314840Updated Jan 2, 2026

Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis

An observational study in Lateral Epicondylitis and Lateral Elbow Tendinopathy (Tennis Elbow), sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-02.

Sponsored by Marmara University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Oct 2025; still recruiting 1 year later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
60
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Lateral epicondylitis (LE) is the tendinopathy of the common extensor tendon. Although exact etiology remains unclear, it is believed to be caused by overuse.

Even though, genetics factor related to tendinopathies were defined accompanying tendinopathies in patients with LE is yet to be studied.

Madrid sonographic enthesitis index (MASEI) is an ultrasound based scoring system, developed for the evaluation of the enthesitis. Initially developed for ankylosing spondylitis, its usage has also become widespread in other musculoskeletal diseases.

The aim of this study is to calculate the MASEI score in patients diagnosed with LE, and compare it to healthy volunteers.

02

Conditions studied

  • Lateral Epicondylitis
  • Lateral Elbow Tendinopathy (Tennis Elbow)

Browse trials for

Keywords

  • Lateral Epicondylitis
  • Lateral Elbow Tendinopathy
  • Tennis Elbow
  • Enthesitis
  • Madrid Sonographic Enthesitis Index
  • MASEI
03

In context

Tennis Elbow

284 studies on the registry are indexed under Tennis Elbow; 60 are open to participants now.

This study's planned enrollment of 60 is below the median of 75 across 26 observational studies indexed under Tennis Elbow.

Browse Tennis Elbow studies →

Lead sponsor

Marmara University is the lead sponsor of 576 studies on the registry; 136 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients presented to the outpatient clinic of Physical Medicine and Rehabilitation of Marmara University with elbow pain and diagnosed with lateral epicondylitis will be informed about the study. Willing patients will be enrolled after written consent is taken.

Control group will be chosen with volunteers, which have similar demographic characteristics.

Inclusion criteria

  • Tenderness with palpation at the lateral epicondyle
  • Pain aggravated with resisted wrist extension

Exclusion criteria

Exclusion Criteria:

  • History of rheumatologic diseases
  • History of elbow, knee or ankle surgery
  • History of corticosteroid injections on elbow, knee or ankle
  • History of peripheral neuropathy
  • Acute trauma
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Lateral Epicondylitis

    Patients with lateral epicondylitis will be included in this group.

    Diagnostic Test: Madrid Sonographic Enthesitis Index

  • Control

    Healthy volunteers with similar demographic characteristics will be enrolled to this group.

    Diagnostic Test: Madrid Sonographic Enthesitis Index

Interventions

  • Diagnostic testMadrid Sonographic Enthesitis Index

    Patients will be evaluated with ultrasound at 6 different locations on each side, for total of 12 locations. These will be insertion points of triceps brachii tendon, quadriceps tendon, proximal and distal patellar tendons, achilles tendon and the plantar fascia. Evaluation parameters are the structure and thickness of the tendon, the presence of calcifications or enthesophytes, erosions in the bone, regional bursitis, and the presence of power-Doppler signal in the entheses.

    Also known as: MASEI

06

What researchers measure

Primary outcomes

  1. Madrid Sonographic Enthesitis Index

    Patients will be evaluated with ultrasound at 6 different locations on each side, for total of 12 locations. At each location; structure and thickness of the tendon, the presence of calcifications or enthesophytes, erosions in the bone, regional bursitis, and the presence of power-Doppler signal will be noted. Each parameter has a point of its own. Points obtained from each parameter will be added and total MASEI score (0-136) will be calculated. Higher scores indicate the presence of enthesitis.

    Time frame: At enrollment

07

Study locations

1 of 1 sites recruiting
  • Marmara University
    Istanbul, Maltepe 34844, Turkey (Türkiye)
    • Arda Can Kasap, MD · Contact · drardakasap@gmail.com · 905384590119
    • Arda Can Kasap, MD · Sub investigator
    • İlker Yağcı, Prof. M.D. · Principal investigator
    • Naime Evrim Karadağ Saygı, Prof. M.D. · Sub investigator
    Recruiting
08

References and documents

Publications

  • Ozsoy-Unubol T, Yagci I. Is ultrasonographic enthesitis evaluation helpful for diagnosis of non-radiographic axial spondyloarthritis? Rheumatol Int. 2018 Nov;38(11):2053-2061. doi: 10.1007/s00296-018-4164-4. Epub 2018 Oct 9. PubMed 30302556 ↗
  • de Miguel E, Cobo T, Munoz-Fernandez S, Naredo E, Uson J, Acebes JC, Andreu JL, Martin-Mola E. Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis. 2009 Feb;68(2):169-74. doi: 10.1136/ard.2007.084251. Epub 2008 Apr 7. PubMed 18390909 ↗
  • Okur SC, Dogan YP, Mert M, Aksu O, Burnaz O, Caglar NS. Ultrasonographic Evaluation of Lower Extremity Entheseal Sites in Diabetic Patients Using Glasgow Ultrasound Enthesitis Scoring System Score. J Med Ultrasound. 2017 Jul-Sep;25(3):150-156. doi: 10.1016/j.jmu.2017.03.011. Epub 2017 May 6. PubMed 30065480 ↗
  • Johns N, Shridhar V. Lateral epicondylitis: Current concepts. Aust J Gen Pract. 2020 Nov;49(11):707-709. doi: 10.31128/AJGP-07-20-5519. PubMed 33123709 ↗
  • Karanasios S, Korakakis V, Moutzouri M, Drakonaki E, Koci K, Pantazopoulou V, Tsepis E, Gioftsos G. Diagnostic accuracy of examination tests for lateral elbow tendinopathy (LET) - A systematic review. J Hand Ther. 2022 Oct-Dec;35(4):541-551. doi: 10.1016/j.jht.2021.02.002. Epub 2021 Feb 27. PubMed 33814224 ↗

Individual participant data

Plan to share: No — Due to legal restrictions, all data will be anonymized. Individual participant data won't be shared to third parties.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07314840
Lead sponsor
Marmara University
Responsible party
İlker Yağcı (Prof. M.D., Marmara University) — Principal investigator
First posted
Jan 2, 2026
Start date
Oct 1, 2025
Primary completion
Jan 31, 2026 (estimated)
Completion
Jan 31, 2026 (estimated)
Last update
Jan 2, 2026

Study contacts

Arda Can Kasap, MD
Contact
drardakasap@gmail.com
905384590119
İlker Yağcı, Prof. Dr.
principal investigator · Acıbadem Ataşehir Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion